AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

VECTUS BIOSYSTEMS LIMITED Share Issue/Capital Change 2023

Dec 3, 2023

65993_rns_2023-12-03_a229d3ea-48a8-472e-989d-d374c0dd9113.pdf

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

==> picture [513 x 94] intentionally omitted <==

4 December 2023

ISSUE OF SHARES

Vectus Biosystems Limited (ASX:VBS) (Vectus or the Company) advises that today it has issued 19,842 new fully paid ordinary shares in Vectus (Shares).

At the Company’s 22 November 2023 Annual General Meeting (AGM) shareholders approved the issue of 19,842 Shares to Chief Executive Officer (CEO) and Executive Director Dr Karen Duggan in satisfaction of amounts owing to her as a bonus under her employment contract for her services as CEO and Executive Director for the year ended 31 December 2022. Full details can be found in the Notice of AGM lodged with ASX on 17 October 2023.

An Appendix 2A for the issue of these shares was lodged with ASX prior to this announcement.

Cleansing Notice Under Section 708A(5)(e)

Vectus advises that on 4 December 2023 the Company issued 19,842 new fully paid ordinary shares, as set out above. Vectus also advises that:

(1) this notice is being given within five business days after the day of the issue under section 708A(5)(e) of the Corporations Act 2001 (Cth);
(2) the Company issued the securities without disclosure to investors under Part 6D.2 of the Corporations Act 2001;
(3) as at the date of this notice, Vectus has complied with:
(a) the provisions of Chapter 2M of the Corporations Act 2001 as they apply to the Company; and
(b) section 674 of the Corporations Act 2001; and
(4) except as may be set out in this notice, there is no other information that is excluded information as at the date of this notice that is required to be set out in this notice under section 708A(6)(e) of the Corporations Act 2001.